Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 1999

View Archived Issues

Alexion commences phase IIb trial of C5 inhibitor for bypass surgery

Icos reviews recent developments at H&Q; new addition to pipeline revealed

Pharmacokinetic studies support safety of novel dental agent

North American Vaccine updates development pipeline at H&Q

Novel compounds developed at Roche for lipid disorders and fungal infections

Cardioprotective benzoylguanidines with improved properties claimed by Hoechst

Indole-based antimigraine agents in development at Allelix

Urea derivatives acting at multiple 5-HT receptor subtypes emerge from SB R&D

Agouron's new MMP inhibitors described in patent literature

Dopamine D3 antagonists for psychoses and other D3 ligands designed at SmithKline Beecham

Seretide cleared for marketing in most E.U. countries

Novel, synthetic ultrasound contrast agent for echocardiography advances to clinical trials

Polish authorities allow phase II testing of Multikine

VP22 increases the efficacy of suicide gene therapy in vivo

Amylin gears up for regulatory filing of pramlintide and presents new clinical data

Millennium and partners extend drug discovery alliances

Amylin files IND for antidiabetes drug and reports on feasibility of alternative delivery routes

Amantadine reverses adverse effects of neuroleptic drugs on sexual function in males

Restructuring and name change announced by VIMRx

Isis and Abbott establish antisense target validation partnership

Combination of lovastatin and acipimox for type II diabetes and mixed dyslipidemia

Avanir requests meeting with FDA regarding Lidakol

Rigel and Janssen enter drug discovery collaboration

Tianeptine, a 5-HT uptake enhancer, demonstrates excellent efficacy in asthma

Onyx expands ONYX-015 clinical trials in liver metastases of colorectal cancer

Synsorb Biotech establishes collaboration with Ocean for novel antibiotic therapies

FDA advisory panel recommends clarification of data for Zila's OraTest

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 18, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 18, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...